Enzolytics Inc.
ENZC
Rank in Stocks
#32561
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is... Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The company possesses patented anti-HIV treatments that have successfully completed clinical testing. Additionally, Enzolytics has developed a unique methodology for manufacturing human IgG1 monoclonal antibodies, intended to provide non-toxic passive immunotherapy against various infectious diseases. A significant achievement includes the creation of a proprietary cell line, specifically engineered to produce human monoclonal antibodies that effectively target and neutralize the human immunodeficiency virus (HIV).
Share Price
$0.0003
Last synced: 2026-11-09
Market Cap
$1.45M
Change (1 day)
-25.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Enzolytics Inc. (ENZC)
Category
Healthcare
Operating Margin for Enzolytics Inc. (ENZC)
Operating Margin as of November 2026 TTM: 0.00%
According to Enzolytics Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Enzolytics Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -4,070.01% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -705.50% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -34,140.00% | 7,849.33% |
| 2017 | -429.47% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | -100.00% |
| 2011 | -1,110.52% | -85.72% |
| 2010 | -7,777.15% | 22.28% |
| 2009 | -6,359.89% | -8.97% |
| 2008 | -6,986.30% | 0.00% |
| 2007 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Enzolytics Inc.'s operating margin
What was Enzolytics Inc.'s operating margin in 2025?
In 2025, Enzolytics Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Enzolytics Inc.'s operating margin changed since 2020?
From 2020 to 2025, Enzolytics Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2023 (-4,070.01%).
How does Enzolytics Inc.'s operating margin compare with similar companies?
Enzolytics Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.